Abits
ABTS
Digihost Technology
DGHI
Argo Blockchain
ARBK
FRMO CORP
FRMO
The9 Ltd
NCTY
Fennec Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in the development of sodium thiosulfate for the prevention of ototoxicity from cisplatin in pediatric cancer patients. The company was founded by Orest W. Blaschuk on September 3, 1996 and is headquartered in Durham, NC.